Satyadeeptha Pharmaceuticals Limited, a active public limited company, was established on 10 March 1987 in Humnabad, Karnataka, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U85110KA1993PLC013900. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹3.88 Cr.
Formerly known as Gladwin Pharmaceuticals Limited. It upholds a compliant status. Employing 166 professional, Its leadership includes Prasada Rao Kalluri (Director), Surapaneni Janardhana Rao (Whole-Time Director), Surapaneni Sarojinidevi (Whole-Time Director). Past directors included Prasada Rao Kalluri, Tummala Venkateswara Rao, Surapaneni Babu Rajendra. It holds ₹145.63 Cr open charges and ₹52.48 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.101A, 101B, 101P1 & 100P4 Industrial Development Area, Humnabad, Karnataka, 585330.
U85110KA1993PLC013900
013900
10 March 1987
₹5.00 Cr
₹3.88 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Satyadeeptha Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prasada Rao Kalluri | Director | 25 Sep 2021 | Current |
| Surapaneni Janardhana Rao | Whole-Time Director | 24 Feb 2023 | Current |
| Surapaneni Sarojinidevi | Whole-Time Director | 20 Mar 1999 | Current |
| Surapaneni Ramakrishna | Managing Director | 18 Jan 1993 | Current |
| Mandapakala Neelalohita | Director | 30 Sep 2025 | Current |
| Sudheer Kumar Aleti | Director | 30 Sep 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Director | 06 Aug 2012 | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | 06 Aug 2012 | Past |
| Pramod Abcsdd | Director | 06 Aug 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Satyadeeptha Pharmaceuticals Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Satyadeeptha Pharmaceuticals had a promoter holding of 95.93% and a public holding of 4.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,456,263,000.00
₹524,829,823.73
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 May 2025 | Others | ₹20.00 Cr | Open |
| 11 Nov 2022 | Hdfc Bank Limited | ₹1.50 Cr | Open |
| 07 Oct 2022 | Hdfc Bank Limited | ₹2.26 Cr | Open |
| 07 Oct 2022 | Hdfc Bank Limited | ₹4.52 Cr | Open |
| 05 Jan 2022 | Canara Bank | ₹3.20 Cr | Open |
Explore comprehensive loan charge details -
Satyadeeptha Pharmaceuticals has a workforce of 166 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Satyadeeptha Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Satyadeeptha Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 22 Apr 2021 via Charge ID 100437986 with Canara Bank was fully satisfied on 15 Oct 2025. was recorded as a recent event.
Progress on Mandapakala Neelalohita was appointed as a Director was appointed as a Director on 30 Sep 2025 & has been associated with this company since 2 months 2 days . was documented.
The activity Sudheer Kumar Aleti was appointed as a Director was appointed as a Director on 30 Sep 2025 & has been associated with this company since 2 months 2 days . was completed.
The activity A charge with Hdfc Bank Limited of Rs. 52.00 Cr registered on 01 Mar 2021 with Charge ID 100436435 was modified on 09 Jun 2025. was completed.
The activity A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101114157 was registered on 12 May 2025. was completed.
Satyadeeptha Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The CIN of Satyadeeptha Pharmaceuticals Limited is U85110KA1993PLC013900.
Satyadeeptha Pharmaceuticals Limited is headquartered at Plot No.101A, 101B, 101P1 & 100P4 Industrial Development Area, Humnabad, Karnataka, 585330.
Satyadeeptha Pharmaceuticals Limited was incorporated on 10 March 1987.
The current directors of Satyadeeptha Pharmaceuticals Limited are
The primary industry of Satyadeeptha Pharmaceuticals Limited is Manufacturing.
Satyadeeptha Pharmaceuticals Limited is unlisted.
The authorized capital of Satyadeeptha Pharmaceuticals Limited is ₹5.00 Cr, and the paid-up capital is ₹3.88 Cr.
The compliance status of Satyadeeptha Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX